Literature DB >> 2965608

The bcl-2 gene is rearranged in many diffuse B-cell lymphomas.

A C Aisenberg1, B M Wilkes, J O Jacobson.   

Abstract

Southern blotting was used to detect rearrangement of the bcl-2 gene in 104 cases of non-Hodgkin's lymphoma subclassified by the Working Formulation, 24 cases of B cell chronic lymphocytic leukemia (B-CLL) and 14 cases of T cell malignancy. Earlier workers reported rearrangement of this gene (located on chromosome 18) in a major fraction of follicular lymphomas, lymphomas in which a 14;18 chromosome translocation is frequently observed. In the present study, bcl-2 was rearranged in 30% (11 of 37) of follicular lymphomas and 19% (11 of 58) of diffuse lymphomas of follicle center cell lineage. In 18 of 19 samples studied, the rearranged bcl-2 fragment also hybridized with a probe for the joining region of the immunoglobulin heavy chain gene located on chromosome 14, indicating a 14;18 translocation. In lymphomas not derived from follicle center cells, ie, diffuse lymphomas of small B lymphocytes, B-CLL and T cell neoplasms, the bcl-2 gene was always in germline configuration. The frequent rearrangement of bcl-2 in a variety of B cell lymphomas of diffuse morphology (small cleaved cell, large cell, small noncleaved cell and immunoblastic) is noteworthy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965608

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.

Authors:  S Colak; C D Zimberlin; E Fessler; L Hogdal; P R Prasetyanti; C M Grandela; A Letai; J P Medema
Journal:  Cell Death Differ       Date:  2014-03-28       Impact factor: 15.828

Review 2.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

3.  The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.

Authors:  E Athan; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

4.  bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.

Authors:  E Athan; D R Foitl; D M Knowles
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

Review 5.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

6.  Detection of bcl-2 and bax expression and bcl-2/JH fusion gene in intrahepatic cholangiocarcinoma.

Authors:  Lin-Lang Guo; Sha Xiao; Ying Guo
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

7.  bcl-2 protein in invasive ductal breast carcinomas.

Authors:  J Hurlimann; B Larrinaga; D L Vala
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 8.  Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes.

Authors:  Vijay Yanamadala; Hideyuki Negoro; Bradley M Denker
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

9.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

Authors:  A Strasser; S Whittingham; D L Vaux; M L Bath; J M Adams; S Cory; A W Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue.

Authors:  R Villuendas; M A Piris; J L Orradre; M Mollejo; R Rodriguez; M Morente
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.